Auxly Cannabis Group Inc.

TSX:XLY.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$3.53 +0.00%

+$0.00 today

Market cap
$364.42M
Beta
1.16
P/E (TTM)
7.3
EPS (TTM)
$0.02
52W Low $0.08High $0.19

Volume 0.13M

Average 0.71M

Returns on capital

Auxly Cannabis Group Inc. management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

23.6%

avg -38.7%

ROIC

13.9%

avg -10.3%

ROA

15.4%

avg -17.0%

Analysis

ROE is currently the strongest return metric at 23.6% versus its period average of -38.7%. 3 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Hugo Alves

Chief Executive Officer & DirectorCAD 2.01M54——

Michael David Lickver

PresidentCAD 1.03M41——

Travis Wong

Chief Financial OfficerCAD 708.25K———

Vladimir Klacar

Senior Vice President of OperationsCAD 708.25K37——

Ron Fichter

General Counsel & Corporate SecretaryCAD 674K———

Andrew MacMillan

Senior Vice President of CommercialCAD 347.8K———

Kevin Furet

Chief Cultivation & Genetics Officer————

Compensation is shown in the reported currency; data updated Nov 7, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

No open-market purchases or sales in the last 12 months.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
+161.1% (3yr)1 analysts
RevenueN/AN/A+17.0%
+14.8% (3yr)1 analysts
Net IncomeN/AN/AN/A
+8.4% (3yr)1 analysts
EBITN/AN/AN/A
+31.3% (3yr)1 analysts

Analysis

Recent growth has been strongest in Revenue at +17.0% over three years. Forward estimates point to EPS at +161.1% (3yr), giving you a quick check on whether expectations are accelerating or cooling.

Competitors

Who does Auxly Cannabis Group Inc. compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about XLY.TO's management, answered from reported figures.

Who manages XLY.TO?

Auxly Cannabis Group Inc. (XLY.TO) lists 7 active executives. The top listed executive is Andrew MacMillan, Senior Vice President of Commercial.